C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV
Trial details
- Registry ID
- NCT06868264
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCVNCT06868264 | AVIR | Phase 3 | Completed | 2026-06-18Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |